{"id":3551,"date":"2011-03-11T17:09:13","date_gmt":"2011-03-11T22:09:13","guid":{"rendered":"http:\/\/sciencebusiness.technewslit.com\/?p=3551"},"modified":"2011-03-11T17:09:13","modified_gmt":"2011-03-11T22:09:13","slug":"finance-friday-11-march-2011","status":"publish","type":"post","link":"https:\/\/technewslit.com\/sciencebusiness\/?p=3551","title":{"rendered":"Finance Friday: 11 March 2011"},"content":{"rendered":"
\"$100<\/a>
(Photos8.com)<\/figcaption><\/figure>\n

Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy<\/a>, Fierce Biotech<\/a>, and Venture Capital Reporter<\/a>.<\/p>\n

Biomedical\/Life Sciences<\/strong><\/p>\n

Kite Pharma, a start up biotech in Los Angeles, California developing new cancer vaccine therapies, took in $15 million in Series A venture funding, from TPG Capital and other investors.<\/p>\n

Euthymics Bioscience Inc. in Braintree, Massachusetts, developing a treatment for adult attention deficit\/hyperactivity disorder, added another $4 million to its series A financing from Novartis Venture Fund and Venture Investors, among others.<\/p>\n

Liquidia Technologies, a biotech working on immune system R&D in Research Triangle Park, North Carolina gained $10 million in equity financing from the Bill & Melinda Gates Foundation.<\/p>\n

Pharmaron, based in China, providing biochemistry R&D services, raised $40 million in the series C financing from existing investors DCM, Legend Capital and a new investor, GL Capital Group.<\/p>\n

Astute Medical in San Diego, California, a maker of new diagnostic tests for acute conditions that require rapid diagnosis, added $13 million in series B equity financing from Domain Associates, Delphi Ventures, De Novo Ventures, and Johnson & Johnson Development Corporation.<\/p>\n

CardioDx in Palo Alto, California, a developer of genomic tests assessing patients\u2019 risk of developing cardiovascular disease, raised $40 million in series E equity financing, led by Longitude Capital.<\/p>\n

Energy and Environment<\/strong><\/p>\n

Grid2Home in San Diego, California, a developer of smart grid software, says it completed a second round of equity funding valued at $2.6 million, led by Granite Ventures.<\/p>\n

Engineering and Electronics<\/strong><\/p>\n

Samplify Systems in Santa Clara, California, a maker of analog chips whose purpose is to make the processing of real world data more sound efficient and thus less expensive, raised $11.2 million in equity funding from\u00a0 Integrated Device Technology, Charles River Ventures, Formative Ventures, and Schlumberger.<\/p>\n

Intermolecular in San Jose, California, an R&D technology developer for semiconductor and clean-energy companies, brought in $15 million in equity and securities sales.<\/p>\n

Physical Sciences<\/strong><\/p>\n

Bubbles & beyond, a German technology company developing liquids and foams for industrial, medical, and other applications, closed a second financing round, raising EUR 1.2 million (USD 1.66 million) from existing investors LBBW Venture Capital, S-Beteiligungen, Hightech-Gruenderfonds, and KfW.<\/p>\n

Read More: Finance Friday: 4 March 2011<\/a><\/p>\n

*\u00a0\u00a0\u00a0\u00a0 *\u00a0\u00a0\u00a0\u00a0 *<\/p>\n","protected":false},"excerpt":{"rendered":"

Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy, Fierce Biotech, and Venture Capital Reporter. Biomedical\/Life Sciences Kite Pharma, a start up biotech in Los Angeles, California developing new cancer vaccine therapies, took in $15 million in Series A venture funding, from TPG Capital and other investors. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[21,72,86,74,23,24,64,105,19],"class_list":["post-3551","post","type-post","status-publish","format-standard","hentry","category-finance","tag-biotech","tag-cleantech","tag-engineering","tag-entrepreneurs","tag-equity","tag-investment","tag-life-sciences","tag-physical-sciences","tag-venture-capital"],"_links":{"self":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/3551","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3551"}],"version-history":[{"count":3,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/3551\/revisions"}],"predecessor-version":[{"id":3554,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=\/wp\/v2\/posts\/3551\/revisions\/3554"}],"wp:attachment":[{"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3551"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3551"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/technewslit.com\/sciencebusiness\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3551"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}